(Q57756608)

English

HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management

article published in 2012

In more languages

edit

Statements

instance of

scholarly article

0 references

title

HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management (English)

0 references

main subject

toll-like receptor

0 references

hepatocellular carcinoma

1 reference

4

Josep M. Llovet

0 references

author name string

Sara Toffanin

series ordinal

1

0 references

Helena Cornella

series ordinal

2

0 references

Andrew Harrington

series ordinal

3

0 references

language of work or name

English

0 references

publication date

31 October 2012

0 references

published in

Hepatology

0 references

volume

56

0 references

issue

5

0 references

page(s)

1998-2000

0 references

cites work

Bacterial translocation and its consequences in patients with cirrhosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Toll-like receptors as targets in chronic liver diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Immunity, Inflammation, and Cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Lymphotoxins: new targets for hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

21 January 2018

Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.26080

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.26080

0 references

PubMed publication ID

23115011

0 references

(Q57756608)

HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)